An Antibody Attack against Body Wasting in Cancer

Maria Rohm; Stephan Herzig

doi:10.1016/j.cmet.2020.08.003

An Antibody Attack against Body Wasting in Cancer

Maria Rohm, Stephan Herzig

Life Sciences

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Abstract

Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals. Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals.

Original language	English
Pages (from-to)	331-333
Number of pages	3
Journal	Cell Metabolism
Volume	32
Issue number	3
DOIs	https://doi.org/10.1016/j.cmet.2020.08.003
State	Published - 1 Sep 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmet.2020.08.003

Cite this

@article{0c3219f42f7f430f8b326ff262048659,

title = "An Antibody Attack against Body Wasting in Cancer",

abstract = "Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals. Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals.",

author = "Maria Rohm and Stephan Herzig",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.cmet.2020.08.003",

language = "English",

volume = "32",

pages = "331--333",

journal = "Cell Metabolism",

issn = "1550-4131",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - An Antibody Attack against Body Wasting in Cancer

AU - Rohm, Maria

AU - Herzig, Stephan

PY - 2020/9/1

Y1 - 2020/9/1

N2 - Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals. Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals.

AB - Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals. Cachexia is a devastating, non-curable condition in many cancer patients that is marked by severe wasting of the muscle and fat tissue. Its prevention has been hampered by an insufficient knowledge of the underlying molecular mechanism(s) that lead to its pathogenesis. Suriben et al. (2020) now report the development and characterization of an antagonistic antibody for the previously identified GDF15-GFRAL axis that efficiently blocks tumor-induced body wasting in experimental animals.

UR - http://www.scopus.com/inward/record.url?scp=85089840638&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2020.08.003

DO - 10.1016/j.cmet.2020.08.003

M3 - Comment/debate

C2 - 32877689

AN - SCOPUS:85089840638

SN - 1550-4131

VL - 32

SP - 331

EP - 333

JO - Cell Metabolism

JF - Cell Metabolism

IS - 3

ER -

An Antibody Attack against Body Wasting in Cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this